Learn
This week in psychedelic business news: The industry's first major merger; NeonMind launches clinics; a portfolio of patents is acquired....
MindMed will present preliminary results from a Phase 2a study treating Generalized Anxiety Disorder with LSD therapy next month....
Psychiatrist, researcher, and CEO of Zylorion Health, Dr. Peter Silverstone, ranks psychedelic medicines based on their potential to revolutionize mental...
This deal will make Numinus the psychedelic medicines company with the highest revenue, though of course there is still a...
Researchers attempt to replicate findings from a 2017 study that found classic psychedelic use conferred reduced risk of past-year opioid...
Clearmind Medicine CEO Adi Zuloff-Shani writes this guest blog about how a new psychoactive molecule called MEAI can treat alcoholism....
This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs seeks more retail investors; a...
The 3rd annual Psychedelics Catalyst Summit at Queen’s University in Kingston, Ontario, will be available to live stream....
The electric pulses could be organized into “trains” that resemble human words, and a vocabulary of “up to 50 words”...
This week in psychedelic business news: TripSitter expands; Enveric files a major patent; and Psychedelic Water raises its profile....